Saito, Tomotaka http://orcid.org/0000-0001-6008-1648
Takenaka, Mamoru
Kuwatani, Masaki
Doi, Shinpei
Ohyama, Hiroshi
Fujisawa, Toshio
Masuda, Atsuhiro
Iwashita, Takuji
Shiomi, Hideyuki
Hayashi, Nobuhiko
Iwata, Keisuke
Maruta, Akinori
Mukai, Tsuyoshi
Matsubara, Saburo
Hamada, Tsuyoshi
Inoue, Tadahisa
Matsumoto, Kazuyuki
Hirose, Sumio
Fujimori, Nao
Kashiwabara, Kosuke
Kamada, Hideki
Hashimoto, Shinichi
Shiratori, Toshiyasu
Yamada, Reiko
Kogure, Hirofumi
Nakahara, Kazunari
Ogura, Takeshi
Kitano, Masayuki
Yasuda, Ichiro
Isayama, Hiroyuki
Nakai, Yousuke http://orcid.org/0000-0001-7411-1385
,
Omoto, Shunsuke
Uemura, Shinya
Nakano, Ryota
Kawase, Yuta
Takahashi, Sho
Okuno, Mitsuru
Iwasa, Yuhei
Yoshida, Kensaku
Ota, Shogo
Tsujimae, Masahiro
Sakai, Arata
Suda, Kentaro
Takahara, Naminatsu
Ishigaki, Kazunaga
Hakuta, Ryunosuke
Sato, Tatsuya
Kitano, Rena
Kan, Motoyasu
Nagashima, Hiroki
Iino, Yotaro
Takahashi, Koji
Kawakubo, Kazumichi
Sugiura, Ryo
Kishi, Kazuma
Yonemura, Hiroki
Nozawa, Shunichiro
Nakabayashi, Ryota
Daisuke, Namima
Hinokuchi, Makoto
Nakaji, So
Nose, Kenji
Saito, Kei
Nomura, Shuzo
Fujisawa, Mariko
Kuniyoshi, Nobuyuki
Okuda, Atsushi
Ueno, Saori
Miyano, Akira
Nishioka, Nobu
Satta, Yusuke
Katsukura, Nobuhiro
Itonaga, Masahiro
Ashida, Reiko
Tamura, Takashi
Shishimoto, Takahiro
Kawaji, Yuki
Kato, Hironari
Sato, Ryosuke
Ueda, Keijiro
Teramatsu, Katsuhito
Matsumoto, Kazuhide
Article History
Received: 25 February 2024
Accepted: 5 August 2024
First Online: 24 August 2024
Declarations
:
: The study protocol was approved by the centralised IRB at The University of Tokyo Hospital (Tokyo, Japan; #2023002P), and subsequently, the approved protocol was approved at the IRB at each collaborating centre. Written informed consent will be obtained from all potential participants. The study was designed and will be implemented according to the guidelines in the Helsinki Declaration []. The current protocol of the WONDER-02 trial is reported according to the SPIRIT reporting guidelines [].
: n/a. In the WONDER-02 trial, we do not plan to describe any details or use images/videos of an individual participant. In case that those data will be required for publication, written informed consent for the publication will be obtained from the corresponding participant. We will be willing to provide a model consent form upon reasonable request.
: H.I. declares research funding from Boston Scientific Japan, Fujifilm, and Piolax Medical Devices; honoraria from Boston Scientific Japan, Century Medical, Create Medic, Fujifilm, Gadelius Medical, Hitachi Medical, Japan Lifeline, Kaneka, Kawasumi Laboratories, Olympus Medical, Piolax Medical Devices, Sumitomo Bakelite, UMIDAS, and Zeon Medical; and contributions from Boston Scientific Japan, Gadelius Medical, Japan Lifeline, and Zeon Medical. Y.N. declares research funding from Boston Scientific Japan, Century Medical, Fujifilm, Gadelius Medical, HOYA Pentax Medical, Hitachi Medical, Kaneka, and Medico’s Hirata; and honoraria from Boston Scientific Japan, Fujifilm, Gadelius Medical, Hitachi Medical, J-MIT, Medico’s Hirata, and Olympus Medical. This work was not supported by any of those companies. The other authors declare no conflicts of interest related to this article.